Cargando…
The evolution of Taiwan’s National Health Insurance drug reimbursement scheme
BACKGROUND: The rapid growth of health care expenditures, especially pharmaceutical spending, is a challenge for many countries. To control increasing pharmaceutical expenditures and to enhance rational use of drugs, Taiwan’s National Health Insurance drug reimbursement system has evolved over time...
Autores principales: | Hsu, Jason C, Lu, Christine Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333892/ https://www.ncbi.nlm.nih.gov/pubmed/25889754 http://dx.doi.org/10.1186/s40199-014-0080-7 |
Ejemplares similares
-
10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan’s National Health Insurance Research Database
por: Hsieh, Hsing-Chun, et al.
Publicado: (2017) -
How does it affect service delivery under the National Health Insurance Scheme in Ghana? Health providers and insurance managers perspective on submission and reimbursement of claims
por: Akweongo, Patricia, et al.
Publicado: (2021) -
The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
por: Mordi, Dumebi O, et al.
Publicado: (2015) -
Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea
por: Shih, Yi‐Ru, et al.
Publicado: (2020) -
Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan’s National Health Insurance Research Database
por: Hsu, Jason C., et al.
Publicado: (2018)